336 related articles for article (PubMed ID: 17884098)
1. Localization of CKII beta subunits in Lewy bodies of Parkinson's disease.
Ryu MY; Kim DW; Arima K; Mouradian MM; Kim SU; Lee G
J Neurol Sci; 2008 Mar; 266(1-2):9-12. PubMed ID: 17884098
[TBL] [Abstract][Full Text] [Related]
2. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
[TBL] [Abstract][Full Text] [Related]
3. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
5. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
6. [The mechanism of Lewy body formation in Parkinson's disease].
Wakabayashi K; Takahashi H
Nihon Rinsho; 2000 Oct; 58(10):2022-7. PubMed ID: 11068441
[TBL] [Abstract][Full Text] [Related]
7. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
[TBL] [Abstract][Full Text] [Related]
8. A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation.
Meredith GE; Halliday GM; Totterdell S
Parkinsonism Relat Disord; 2004 Jun; 10(4):191-202. PubMed ID: 15120093
[TBL] [Abstract][Full Text] [Related]
9. Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra.
Yamamoto S; Fukae J; Mori H; Mizuno Y; Hattori N
Neurosci Lett; 2006 Apr; 396(3):187-91. PubMed ID: 16386370
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders.
Tanji K; Mori F; Kakita A; Zhang H; Kito K; Kamitani T; Takahashi H; Wakabayashi K
Acta Neuropathol; 2007 Oct; 114(4):365-71. PubMed ID: 17549501
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
Lee VM; Trojanowski JQ
Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
[TBL] [Abstract][Full Text] [Related]
13. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
[TBL] [Abstract][Full Text] [Related]
14. Association of Lewy bodies and glial cytoplasmic inclusions in the brain of Parkinson's disease.
Mochizuki A; Komatsuzaki Y; Shoji S
Acta Neuropathol; 2002 Nov; 104(5):534-7. PubMed ID: 12410401
[TBL] [Abstract][Full Text] [Related]
15. Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease.
Braak H; Sastre M; Del Tredici K
Acta Neuropathol; 2007 Sep; 114(3):231-41. PubMed ID: 17576580
[TBL] [Abstract][Full Text] [Related]
16. alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.
Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
Acta Neuropathol; 2010 Jun; 119(6):723-35. PubMed ID: 20383714
[TBL] [Abstract][Full Text] [Related]
17. Pro-apoptotic protein glyceraldehyde-3-phosphate dehydrogenase promotes the formation of Lewy body-like inclusions.
Tsuchiya K; Tajima H; Kuwae T; Takeshima T; Nakano T; Tanaka M; Sunaga K; Fukuhara Y; Nakashima K; Ohama E; Mochizuki H; Mizuno Y; Katsube N; Ishitani R
Eur J Neurosci; 2005 Jan; 21(2):317-26. PubMed ID: 15673432
[TBL] [Abstract][Full Text] [Related]
18. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
Iwatsubo T
J Neurol; 2003 Oct; 250 Suppl 3():III11-4. PubMed ID: 14579119
[TBL] [Abstract][Full Text] [Related]
19. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.
Shirakashi Y; Kawamoto Y; Tomimoto H; Takahashi R; Ihara M
Acta Neuropathol; 2006 Dec; 112(6):681-9. PubMed ID: 16957925
[TBL] [Abstract][Full Text] [Related]
20. Casein kinase II-mediated phosphorylation regulates alpha-synuclein/synphilin-1 interaction and inclusion body formation.
Lee G; Tanaka M; Park K; Lee SS; Kim YM; Junn E; Lee SH; Mouradian MM
J Biol Chem; 2004 Feb; 279(8):6834-9. PubMed ID: 14645218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]